Metrizamide and metrizoate for cardioangiography in infants and children
Acta Radiologica: Diagnosis
G StakeS J Sørland
Metrizamide was compared with metrizoate in a double blind investigation. Cardioangiography was performed in 30 infants and children below 2 years of age with congenital heart disease. Adverse reactions were few and unimportant. Changes in ECG, ventricular pressure and heart rate during and after the contrast injections were recorded. The side effects were slight in both groups. Metrizamide caused less changes than metrizoate at a statistically significant level.
Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.